John A. Mankovich
Papers
1
Total Citations
11
H-Index
1
About
John A. Mankovich is a structural biologist and drug discovery researcher whose work bridges the gap between protein engineering and rational drug design. His primary research focuses on the application of mutagenesis strategies to support structure-based drug design, particularly in the context of kinase targets. His most notable contribution, the 2009 paper "Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study," demonstrates how targeted protein modifications can enable the crystallization and structural characterization of challenging therapeutic targets. This work, which has accumulated 11 citations, provides a methodological framework for overcoming common obstacles in kinase structural biology, such as protein flexibility and poor diffraction quality. By using MAPKAP kinase 2 as a model system, Mankovich’s research has helped advance the understanding of how rational mutagenesis can facilitate the development of selective inhibitors. His contributions are particularly valuable for researchers in structural genomics and pharmaceutical development, offering practical solutions for enabling structure-guided drug discovery in difficult protein targets.
Research Focus
Key Achievements
Top Papers
- 1